nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—adrenal gland cancer	0.593	0.734	CbGaD
Acetylsalicylic acid—PTGS2—adrenal gland cancer	0.116	0.144	CbGaD
Acetylsalicylic acid—ABCB1—adrenal gland cancer	0.0987	0.122	CbGaD
Acetylsalicylic acid—CYP2C19—urine—adrenal gland cancer	0.00269	0.052	CbGeAlD
Acetylsalicylic acid—NFKBIA—adrenal cortex—adrenal gland cancer	0.00246	0.0476	CbGeAlD
Acetylsalicylic acid—HSPA5—adrenal cortex—adrenal gland cancer	0.00241	0.0466	CbGeAlD
Acetylsalicylic acid—CYP2C9—urine—adrenal gland cancer	0.00209	0.0403	CbGeAlD
Acetylsalicylic acid—TP53—gonad—adrenal gland cancer	0.00207	0.0401	CbGeAlD
Acetylsalicylic acid—RPS6KA3—adrenal cortex—adrenal gland cancer	0.00205	0.0397	CbGeAlD
Acetylsalicylic acid—NFKBIA—gonad—adrenal gland cancer	0.00204	0.0394	CbGeAlD
Acetylsalicylic acid—NFKBIA—cardiac atrium—adrenal gland cancer	0.00204	0.0394	CbGeAlD
Acetylsalicylic acid—TP53—pituitary gland—adrenal gland cancer	0.00202	0.0391	CbGeAlD
Acetylsalicylic acid—HSPA5—gonad—adrenal gland cancer	0.002	0.0386	CbGeAlD
Acetylsalicylic acid—HSPA5—cardiac atrium—adrenal gland cancer	0.00199	0.0386	CbGeAlD
Acetylsalicylic acid—NFKBIA—pituitary gland—adrenal gland cancer	0.00199	0.0385	CbGeAlD
Acetylsalicylic acid—HSPA5—pituitary gland—adrenal gland cancer	0.00195	0.0377	CbGeAlD
Acetylsalicylic acid—TP53—adrenal gland—adrenal gland cancer	0.00181	0.0349	CbGeAlD
Acetylsalicylic acid—NFKBIA—adrenal gland—adrenal gland cancer	0.00178	0.0344	CbGeAlD
Acetylsalicylic acid—HSPA5—adrenal gland—adrenal gland cancer	0.00174	0.0337	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cardiac atrium—adrenal gland cancer	0.0017	0.0329	CbGeAlD
Acetylsalicylic acid—EDNRA—adrenal cortex—adrenal gland cancer	0.00167	0.0323	CbGeAlD
Acetylsalicylic acid—RPS6KA3—pituitary gland—adrenal gland cancer	0.00166	0.0321	CbGeAlD
Acetylsalicylic acid—RPS6KA3—adrenal gland—adrenal gland cancer	0.00148	0.0287	CbGeAlD
Acetylsalicylic acid—EDNRA—cardiac atrium—adrenal gland cancer	0.00138	0.0267	CbGeAlD
Acetylsalicylic acid—EDNRA—pituitary gland—adrenal gland cancer	0.00135	0.0261	CbGeAlD
Acetylsalicylic acid—IKBKB—gonad—adrenal gland cancer	0.00126	0.0243	CbGeAlD
Acetylsalicylic acid—IKBKB—pituitary gland—adrenal gland cancer	0.00123	0.0237	CbGeAlD
Acetylsalicylic acid—EDNRA—adrenal gland—adrenal gland cancer	0.00121	0.0233	CbGeAlD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—adrenal gland cancer	0.00111	0.306	CrCbGaD
Acetylsalicylic acid—IKBKB—adrenal gland—adrenal gland cancer	0.00109	0.0212	CbGeAlD
Acetylsalicylic acid—Salsalate—PTGS2—adrenal gland cancer	0.000645	0.178	CrCbGaD
Acetylsalicylic acid—ALB—adrenal gland—adrenal gland cancer	0.000639	0.0124	CbGeAlD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—adrenal gland cancer	0.000635	0.176	CrCbGaD
Acetylsalicylic acid—CYP2C8—pituitary gland—adrenal gland cancer	0.000503	0.00972	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—PTGS2—adrenal gland cancer	0.000494	0.137	CrCbGaD
Acetylsalicylic acid—PTGS2—adrenal cortex—adrenal gland cancer	0.000482	0.00933	CbGeAlD
Acetylsalicylic acid—PTGS1—cardiac atrium—adrenal gland cancer	0.000417	0.00807	CbGeAlD
Acetylsalicylic acid—PTGS1—pituitary gland—adrenal gland cancer	0.000408	0.00788	CbGeAlD
Acetylsalicylic acid—Salicylic acid—PTGS2—adrenal gland cancer	0.000397	0.11	CrCbGaD
Acetylsalicylic acid—PTGS2—pituitary gland—adrenal gland cancer	0.00039	0.00754	CbGeAlD
Acetylsalicylic acid—PTGS1—adrenal gland—adrenal gland cancer	0.000364	0.00704	CbGeAlD
Acetylsalicylic acid—PTGS2—adrenal gland—adrenal gland cancer	0.000348	0.00673	CbGeAlD
Acetylsalicylic acid—Salicylic acid—ABCB1—adrenal gland cancer	0.000337	0.0933	CrCbGaD
Acetylsalicylic acid—ABCB1—adrenal cortex—adrenal gland cancer	0.000298	0.00577	CbGeAlD
Acetylsalicylic acid—ABCB1—gonad—adrenal gland cancer	0.000247	0.00478	CbGeAlD
Acetylsalicylic acid—ABCB1—pituitary gland—adrenal gland cancer	0.000241	0.00466	CbGeAlD
Acetylsalicylic acid—ABCB1—adrenal gland—adrenal gland cancer	0.000215	0.00416	CbGeAlD
Acetylsalicylic acid—RPS6KA3—Axon guidance—EGFR—adrenal gland cancer	4.87e-05	0.000357	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GNRHR—adrenal gland cancer	4.86e-05	0.000356	CbGpPWpGaD
Acetylsalicylic acid—SLC22A6—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.84e-05	0.000354	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—TP53—adrenal gland cancer	4.82e-05	0.000353	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	4.78e-05	0.00035	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—PRKACA—adrenal gland cancer	4.75e-05	0.000348	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—BRAF—adrenal gland cancer	4.67e-05	0.000342	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	4.63e-05	0.000339	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	4.61e-05	0.000337	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SH3KBP1—adrenal gland cancer	4.52e-05	0.000331	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.48e-05	0.000328	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CDC42—adrenal gland cancer	4.44e-05	0.000325	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—BAD—adrenal gland cancer	4.43e-05	0.000324	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—CTNNB1—adrenal gland cancer	4.4e-05	0.000322	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—CTNNB1—adrenal gland cancer	4.39e-05	0.000321	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—CTNNB1—adrenal gland cancer	4.33e-05	0.000317	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IGF2—adrenal gland cancer	4.28e-05	0.000313	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ZNRF3—adrenal gland cancer	4.25e-05	0.000311	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—GNAS—adrenal gland cancer	4.24e-05	0.000311	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SH3KBP1—adrenal gland cancer	4.22e-05	0.000309	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CDC42—adrenal gland cancer	4.2e-05	0.000307	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PRKACA—adrenal gland cancer	4.19e-05	0.000307	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—SDHB—adrenal gland cancer	4.15e-05	0.000304	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PRKACA—adrenal gland cancer	4.14e-05	0.000303	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IGF1R—adrenal gland cancer	4.14e-05	0.000303	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.12e-05	0.000301	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—adrenal gland cancer	4.12e-05	0.000301	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—EGFR—adrenal gland cancer	4.1e-05	0.0003	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CDC42—adrenal gland cancer	4.03e-05	0.000295	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—BRAF—adrenal gland cancer	4.03e-05	0.000295	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ZNRF3—adrenal gland cancer	3.96e-05	0.00029	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	3.93e-05	0.000288	CbGpPWpGaD
Acetylsalicylic acid—SLC22A6—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.92e-05	0.000287	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—CTNNB1—adrenal gland cancer	3.87e-05	0.000284	CbGpPWpGaD
Acetylsalicylic acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	3.85e-05	0.000282	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—TP53—adrenal gland cancer	3.84e-05	0.000281	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—BAD—adrenal gland cancer	3.84e-05	0.000281	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—POMC—adrenal gland cancer	3.81e-05	0.000279	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	3.78e-05	0.000277	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PRKACA—adrenal gland cancer	3.75e-05	0.000274	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PRKACA—adrenal gland cancer	3.75e-05	0.000274	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.65e-05	0.000267	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—EGFR—adrenal gland cancer	3.64e-05	0.000266	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.62e-05	0.000265	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TERT—adrenal gland cancer	3.56e-05	0.000261	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CDC42—adrenal gland cancer	3.55e-05	0.00026	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—EGFR—adrenal gland cancer	3.55e-05	0.00026	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CDC42—adrenal gland cancer	3.51e-05	0.000257	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—EGFR—adrenal gland cancer	3.48e-05	0.000255	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—EGFR—adrenal gland cancer	3.48e-05	0.000254	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—POMC—adrenal gland cancer	3.46e-05	0.000253	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—POMC—adrenal gland cancer	3.46e-05	0.000253	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—SPARC—adrenal gland cancer	3.44e-05	0.000252	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TP53—adrenal gland cancer	3.44e-05	0.000252	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—EGFR—adrenal gland cancer	3.43e-05	0.000251	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—BAD—adrenal gland cancer	3.43e-05	0.000251	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IGF2—adrenal gland cancer	3.43e-05	0.000251	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—POMC—adrenal gland cancer	3.42e-05	0.00025	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—GNAS—adrenal gland cancer	3.4e-05	0.000249	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IGF2—adrenal gland cancer	3.39e-05	0.000248	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SDHB—adrenal gland cancer	3.38e-05	0.000247	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	3.37e-05	0.000247	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—SDHD—adrenal gland cancer	3.37e-05	0.000247	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—RRM1—adrenal gland cancer	3.37e-05	0.000247	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SDHB—adrenal gland cancer	3.36e-05	0.000246	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—GNAS—adrenal gland cancer	3.36e-05	0.000246	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IGF1R—adrenal gland cancer	3.31e-05	0.000243	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—EGFR—adrenal gland cancer	3.3e-05	0.000241	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	3.28e-05	0.00024	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IGF1R—adrenal gland cancer	3.27e-05	0.00024	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.27e-05	0.000239	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.25e-05	0.000238	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—PTGS2—adrenal gland cancer	3.25e-05	0.000238	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CDC42—adrenal gland cancer	3.18e-05	0.000233	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CDC42—adrenal gland cancer	3.18e-05	0.000233	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—BAD—adrenal gland cancer	3.1e-05	0.000227	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	3.08e-05	0.000225	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—EGFR—adrenal gland cancer	3.07e-05	0.000225	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IGF2—adrenal gland cancer	3.06e-05	0.000224	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IGF2—adrenal gland cancer	3.06e-05	0.000224	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	3.05e-05	0.000223	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—GNAS—adrenal gland cancer	3.04e-05	0.000222	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—GNAS—adrenal gland cancer	3.04e-05	0.000222	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SDHB—adrenal gland cancer	3.02e-05	0.000221	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TP53—adrenal gland cancer	2.98e-05	0.000218	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.97e-05	0.000217	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IGF1R—adrenal gland cancer	2.96e-05	0.000217	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IGF1R—adrenal gland cancer	2.96e-05	0.000217	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SDHB—adrenal gland cancer	2.94e-05	0.000216	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—BAD—adrenal gland cancer	2.93e-05	0.000214	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GNRH1—adrenal gland cancer	2.91e-05	0.000213	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—CTNNB1—adrenal gland cancer	2.91e-05	0.000213	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PRKACA—adrenal gland cancer	2.9e-05	0.000213	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PRKACA—adrenal gland cancer	2.88e-05	0.000211	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—POMC—adrenal gland cancer	2.86e-05	0.000209	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TERT—adrenal gland cancer	2.85e-05	0.000209	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—BRAF—adrenal gland cancer	2.82e-05	0.000206	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TERT—adrenal gland cancer	2.82e-05	0.000206	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—BAD—adrenal gland cancer	2.81e-05	0.000206	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SDHB—adrenal gland cancer	2.75e-05	0.000201	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PTGS2—adrenal gland cancer	2.72e-05	0.000199	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—EGFR—adrenal gland cancer	2.68e-05	0.000196	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—RRM1—adrenal gland cancer	2.68e-05	0.000196	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—SDHD—adrenal gland cancer	2.68e-05	0.000196	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SPRY2—adrenal gland cancer	2.66e-05	0.000195	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.66e-05	0.000195	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.64e-05	0.000194	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TSHR—adrenal gland cancer	2.6e-05	0.00019	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TERT—adrenal gland cancer	2.55e-05	0.000187	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TERT—adrenal gland cancer	2.55e-05	0.000187	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CTNNB1—adrenal gland cancer	2.52e-05	0.000185	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.51e-05	0.000184	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—MED12—adrenal gland cancer	2.51e-05	0.000184	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SPRY2—adrenal gland cancer	2.49e-05	0.000182	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—BAD—adrenal gland cancer	2.48e-05	0.000182	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—CDC42—adrenal gland cancer	2.46e-05	0.00018	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—BAD—adrenal gland cancer	2.45e-05	0.00018	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDC42—adrenal gland cancer	2.44e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MEN1—adrenal gland cancer	2.44e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	2.42e-05	0.000177	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2.42e-05	0.000177	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IGF2—adrenal gland cancer	2.37e-05	0.000174	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.37e-05	0.000174	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—GNAS—adrenal gland cancer	2.35e-05	0.000172	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—EGFR—adrenal gland cancer	2.31e-05	0.000169	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—POMC—adrenal gland cancer	2.29e-05	0.000167	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MEN1—adrenal gland cancer	2.28e-05	0.000167	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—POMC—adrenal gland cancer	2.26e-05	0.000165	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—BRAF—adrenal gland cancer	2.26e-05	0.000165	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CTNNB1—adrenal gland cancer	2.26e-05	0.000165	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.25e-05	0.000164	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—BRAF—adrenal gland cancer	2.23e-05	0.000163	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—BAD—adrenal gland cancer	2.22e-05	0.000162	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—BAD—adrenal gland cancer	2.22e-05	0.000162	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.2e-05	0.000161	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SDHD—adrenal gland cancer	2.18e-05	0.000159	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—RRM1—adrenal gland cancer	2.18e-05	0.000159	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—RRM1—adrenal gland cancer	2.17e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SDHD—adrenal gland cancer	2.17e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.16e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	2.16e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—POMC—adrenal gland cancer	2.04e-05	0.00015	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—POMC—adrenal gland cancer	2.04e-05	0.00015	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.04e-05	0.000149	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.04e-05	0.000149	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.03e-05	0.000148	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—BRAF—adrenal gland cancer	2.02e-05	0.000148	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—BRAF—adrenal gland cancer	2.02e-05	0.000148	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—EGFR—adrenal gland cancer	2e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MED12—adrenal gland cancer	2e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—EGFR—adrenal gland cancer	1.96e-05	0.000143	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—EGFR—adrenal gland cancer	1.96e-05	0.000143	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SDHD—adrenal gland cancer	1.94e-05	0.000142	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—RRM1—adrenal gland cancer	1.94e-05	0.000142	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CTNNB1—adrenal gland cancer	1.93e-05	0.000141	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—RRM1—adrenal gland cancer	1.9e-05	0.000139	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SDHD—adrenal gland cancer	1.9e-05	0.000139	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PRKACA—adrenal gland cancer	1.86e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PRKACA—adrenal gland cancer	1.83e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.79e-05	0.000131	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—EGFR—adrenal gland cancer	1.79e-05	0.000131	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.79e-05	0.000131	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.78e-05	0.000131	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—RRM1—adrenal gland cancer	1.77e-05	0.00013	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SDHD—adrenal gland cancer	1.77e-05	0.00013	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PRKACA—adrenal gland cancer	1.74e-05	0.000127	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	1.71e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—BAD—adrenal gland cancer	1.71e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CTNNB1—adrenal gland cancer	1.63e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MED12—adrenal gland cancer	1.62e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EGFR—adrenal gland cancer	1.62e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MED12—adrenal gland cancer	1.61e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CTNNB1—adrenal gland cancer	1.61e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDC42—adrenal gland cancer	1.58e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EGFR—adrenal gland cancer	1.53e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF2—adrenal gland cancer	1.52e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GNAS—adrenal gland cancer	1.51e-05	0.000111	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GNAS—adrenal gland cancer	1.49e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDC42—adrenal gland cancer	1.47e-05	0.000108	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF1R—adrenal gland cancer	1.47e-05	0.000108	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—EGFR—adrenal gland cancer	1.47e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CTNNB1—adrenal gland cancer	1.46e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CTNNB1—adrenal gland cancer	1.46e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ABCB1—adrenal gland cancer	1.46e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PRKACA—adrenal gland cancer	1.46e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.45e-05	0.000106	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MED12—adrenal gland cancer	1.45e-05	0.000106	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.44e-05	0.000106	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.44e-05	0.000105	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MED12—adrenal gland cancer	1.41e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—adrenal gland cancer	1.36e-05	9.93e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MED12—adrenal gland cancer	1.32e-05	9.67e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.3e-05	9.48e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EGFR—adrenal gland cancer	1.29e-05	9.47e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EGFR—adrenal gland cancer	1.28e-05	9.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TERT—adrenal gland cancer	1.27e-05	9.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	1.18e-05	8.67e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TERT—adrenal gland cancer	1.18e-05	8.66e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.18e-05	8.65e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GNAS—adrenal gland cancer	1.18e-05	8.64e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PRKACA—adrenal gland cancer	1.18e-05	8.62e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ABCB1—adrenal gland cancer	1.16e-05	8.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.16e-05	8.47e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EGFR—adrenal gland cancer	1.16e-05	8.46e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EGFR—adrenal gland cancer	1.16e-05	8.46e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.15e-05	8.43e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CTNNB1—adrenal gland cancer	1.12e-05	8.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—BAD—adrenal gland cancer	1.1e-05	8.07e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—adrenal gland cancer	1.09e-05	7.95e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	1.06e-05	7.74e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.03e-05	7.56e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.03e-05	7.55e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—BAD—adrenal gland cancer	1.03e-05	7.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—POMC—adrenal gland cancer	1.02e-05	7.44e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—BRAF—adrenal gland cancer	1e-05	7.35e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—POMC—adrenal gland cancer	1e-05	7.32e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—adrenal gland cancer	9.71e-06	7.1e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—adrenal gland cancer	9.71e-06	7.1e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	9.64e-06	7.06e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GNAS—adrenal gland cancer	9.6e-06	7.03e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GNAS—adrenal gland cancer	9.54e-06	6.99e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	9.42e-06	6.9e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	9.42e-06	6.9e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—BRAF—adrenal gland cancer	9.37e-06	6.86e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ABCB1—adrenal gland cancer	9.37e-06	6.86e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—adrenal gland cancer	8.89e-06	6.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GNAS—adrenal gland cancer	8.57e-06	6.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	8.41e-06	6.15e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GNAS—adrenal gland cancer	8.36e-06	6.12e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—adrenal gland cancer	7.98e-06	5.84e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—POMC—adrenal gland cancer	7.94e-06	5.81e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GNAS—adrenal gland cancer	7.81e-06	5.72e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	7.67e-06	5.61e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—adrenal gland cancer	7.52e-06	5.51e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CTNNB1—adrenal gland cancer	7.26e-06	5.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CTNNB1—adrenal gland cancer	6.77e-06	4.96e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—POMC—adrenal gland cancer	6.46e-06	4.73e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—POMC—adrenal gland cancer	6.43e-06	4.7e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—POMC—adrenal gland cancer	5.77e-06	4.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—adrenal gland cancer	5.75e-06	4.21e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—POMC—adrenal gland cancer	5.63e-06	4.12e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—adrenal gland cancer	5.36e-06	3.93e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—POMC—adrenal gland cancer	5.26e-06	3.85e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	5.16e-06	3.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—adrenal gland cancer	5.13e-06	3.75e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—adrenal gland cancer	4.83e-06	3.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	4.6e-06	3.37e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—adrenal gland cancer	4.49e-06	3.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	4.2e-06	3.07e-05	CbGpPWpGaD
